{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:46:50Z","timestamp":1787701610160,"version":"build-2784847793"},"reference-count":93,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.hfc.2010.05.004","type":"journal-article","created":{"date-parts":[[2010,9,25]],"date-time":"2010-09-25T04:43:58Z","timestamp":1285389838000},"page":"433-444","source":"Crossref","is-referenced-by-count":58,"title":["Hypertrophic Cardiomyopathy in Childhood"],"prefix":"10.1016","volume":"6","author":[{"given":"Steven D.","family":"Colan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.hfc.2010.05.004_bib1","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa021715","article-title":"The incidence of pediatric cardiomyopathy in two regions of the United States","volume":"348","author":"Lipshultz","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2010.05.004_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/hrt.81.2.141","article-title":"Marked variation in the cardiomyopathy associated with Friedreich's ataxia","volume":"81","author":"Dutka","year":"1999","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.hfc.2010.05.004_bib3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s002469900471","article-title":"Infantile hypertrophic cardiomyopathy of glycogenosis Type IX: isolated cardiac phosphorylase kinase deficiency","volume":"20","author":"Regalado","year":"1999","journal-title":"Pediatr Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2010.05.004_bib4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.106.621185","article-title":"Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry","volume":"115","author":"Colan","year":"2007","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hfc.2010.05.004_bib5","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.CIR.0000056522.82563.5F","article-title":"Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy","volume":"107","author":"Geier","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2009.02.075","article-title":"Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy","volume":"54","author":"Bos","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2010.05.004_bib7","doi-asserted-by":"crossref","first-page":"C225","DOI":"10.1152\/ajpcell.1999.277.2.C225","article-title":"Functional changes in troponin T by a splice donor site mutation that causes hypertrophic cardiomyopathy","volume":"277","author":"Nakaura","year":"1999","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"10.1016\/j.hfc.2010.05.004_bib8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1006\/jmcc.2001.1340","article-title":"The molecular genetic basis for hypertrophic cardiomyopathy","volume":"33","author":"Marian","year":"2001","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI0214571","article-title":"Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy","volume":"109","author":"Arad","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.hfc.2010.05.004_bib10","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.jacc.2004.08.027","article-title":"Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy","volume":"44","author":"Mogensen","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0735-1097(96)00530-X","article-title":"Sudden death due to troponin T mutations","volume":"29","author":"Moolman","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2010.05.004_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.98.5.391","article-title":"Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis","volume":"98","author":"Anan","year":"1998","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2010.05.004_bib13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/hrt.80.6.548","article-title":"Coexistence of mitochondrial DNA and \u03b2 myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure","volume":"80","author":"Arbustini","year":"1998","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.hfc.2010.05.004_bib14","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2004.07.045","article-title":"Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy","volume":"44","author":"Van Driest","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/heart.87.3.270","volume":"87","author":"Ortlepp","year":"2002","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.hfc.2010.05.004_bib16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/hrt.78.2.110","article-title":"The phenotype\/genotype relation and the current status of genetic screening in hypertrophic cardiomyopathy, Marfan syndrome, and the long QT syndrome","volume":"78","author":"Burn","year":"1997","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.hfc.2010.05.004_bib17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1172\/JCI200214677","article-title":"The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model","volume":"109","author":"Semsarian","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.hfc.2010.05.004_bib18","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0735-1097(87)80232-2","article-title":"Physiologic hypertrophy: effects on left ventricular systolic mechanics in athletes","volume":"9","author":"Colan","year":"1987","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.hfc.2010.05.004_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/bjsm.2008.054726","article-title":"Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening","volume":"43","author":"Maron","year":"2009","journal-title":"Br J Sports Med"},{"issue":"2","key":"10.1016\/j.hfc.2010.05.004_bib20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1152\/japplphysiol.01144.2004","article-title":"Theoretical and empirical derivation of cardiovascular allometric relationships in children","volume":"99","author":"Sluysmans","year":"2005","journal-title":"J\u00a0Appl Physiol"},{"issue":"9","key":"10.1016\/j.hfc.2010.05.004_bib21","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/euhj.1998.1049","article-title":"Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children","volume":"19","author":"Charron","year":"1998","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hfc.2010.05.004_bib22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/01.CIR.0000084500.72232.8D","article-title":"Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease","volume":"108","author":"Nagueh","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ahj.2005.12.005","article-title":"Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes","volume":"151","author":"Poutanen","year":"2006","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.hfc.2010.05.004_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1444-2892.2002.00121.x","article-title":"Tissue doppler imaging in hypertrophic cardiomyopathy without left ventricular hypertrophy","volume":"11","author":"McTaggart","year":"2002","journal-title":"Heart Lung Circ"},{"issue":"24","key":"10.1016\/j.hfc.2010.05.004_bib25","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2008.08.055","article-title":"Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities","volume":"52","author":"Pelliccia","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jacc.2008.11.069","volume":"54","author":"Maron","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2010.05.004_bib27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hfc.2010.05.004_bib28","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/hrt.2007.126003","article-title":"Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy","volume":"94","author":"Shah","year":"2008","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.hfc.2010.05.004_bib29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.CIR.97.5.461","article-title":"Spontaneous variability of left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy","volume":"97","author":"Kizilbash","year":"1998","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2010.05.004_bib30","first-page":"1813","article-title":"A\u00a0cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment","volume":"34","author":"Ostman-Smith","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2010.05.004_bib31","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00005344-199424060-00015","article-title":"Acute intravenous versus chronic oral drug effects of verapamil on left ventricular diastolic function in patients with hypertrophic cardiomyopathy","volume":"24","author":"Posma","year":"1994","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"8","key":"10.1016\/j.hfc.2010.05.004_bib32","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/000331979604700803","article-title":"Persisting effect of Ca(2+)-channel blockers on left ventricular function in hypertrophic cardiomyopathy after 14 years' treatment","volume":"47","author":"Hartmann","year":"1996","journal-title":"Angiology"},{"issue":"4","key":"10.1016\/j.hfc.2010.05.004_bib33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9149(94)90404-9","article-title":"Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy","volume":"74","author":"Gistri","year":"1994","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib34","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1017\/S1047951100006818","article-title":"Verapamil therapy in infants with hypertrophic cardiomyopathy","volume":"8","author":"Moran","year":"1998","journal-title":"Cardiol Young"},{"issue":"14","key":"10.1016\/j.hfc.2010.05.004_bib35","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/01.CIR.97.14.1342","article-title":"Effects of cardiac versus circulatory angiotensin-converting enzyme inhibition on left ventricular diastolic function and coronary blood flow in hypertrophic obstructive cardiomyopathy","volume":"97","author":"Kyriakidis","year":"1998","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hfc.2010.05.004_bib36","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000121426.43044.2B","article-title":"Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy","volume":"109","author":"Tsybouleva","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2010.05.004_bib37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1536\/ihj.48.715","article-title":"A\u00a0new therapeutic strategy for hypertrophic nonobstructive cardiomyopathy in humans. A randomized and prospective study with an Angiotensin II receptor blocker","volume":"48","author":"Yamazaki","year":"2007","journal-title":"Int Heart J"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1540-8175.1998.tb00609.x","article-title":"Mid-term results of dual-chamber pacing in children with hypertrophic obstructive cardiomyopathy","volume":"15","author":"Alday","year":"1998","journal-title":"Echocardiography"},{"issue":"4","key":"10.1016\/j.hfc.2010.05.004_bib39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0735-1097(96)00591-8","article-title":"Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy","volume":"29","author":"Rishi","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2010.05.004_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijcard.2003.03.010","article-title":"Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy","volume":"94","author":"Dimitrow","year":"2004","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2010.05.004_bib41","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1161\/01.CIR.90.6.2731","article-title":"Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy","volume":"90","author":"Fananapazir","year":"1994","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2010.05.004_bib42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0735-1097(96)00473-1","article-title":"Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial","volume":"29","author":"Nishimura","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2010.05.004_bib43","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0002-9149(98)01065-0","article-title":"Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy","volume":"83","author":"Linde","year":"1999","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2010.05.004_bib44","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.85.6.2149","article-title":"Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and \u03b2-adrenergic blocker therapy","volume":"85","author":"Fananapazir","year":"1992","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2010.05.004_bib45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0002-9149(98)00912-6","article-title":"Rapid return of left ventricular outflow tract obstruction and symptoms following cessation of long-term atrioventricular synchronous pacing for obstructive hypertrophic cardiomyopathy","volume":"83","author":"Gadler","year":"1999","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib46","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/eurheartj\/ehm561","article-title":"Septal myectomy: cut, coil, or boil?","volume":"29","author":"Togni","year":"2008","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hfc.2010.05.004_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.107.738740","article-title":"Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"118","author":"Sorajja","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2010.05.004_bib48","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/01.CIR.0000114144.40315.C0","article-title":"Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy","volume":"109","author":"Kimmelstiel","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib49","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/eurheartj\/ehm632","article-title":"Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up","volume":"29","author":"Durand","year":"2008","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.hfc.2010.05.004_bib50","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/01.CIR.0000162460.36735.71","article-title":"Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy","volume":"111","author":"Woo","year":"2005","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.hfc.2010.05.004_bib51","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMcp030779","article-title":"Hypertrophic obstructive cardiomyopathy","volume":"350","author":"Nishimura","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hfc.2010.05.004_bib52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.athoracsur.2007.07.063","article-title":"Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy","volume":"85","author":"Smedira","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.hfc.2010.05.004_bib53","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.athoracsur.2005.03.109","article-title":"Septal myectomy for obstructive hypertrophic cardiomyopathy in pediatric patients: early and late results","volume":"80","author":"Minakata","year":"2005","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.hfc.2010.05.004_bib54","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.echo.2007.11.006","article-title":"Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy","volume":"21","author":"Menon","year":"2008","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib55","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.athoracsur.2005.03.108","article-title":"Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy","volume":"80","author":"Minakata","year":"2005","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib56","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1445-5994.1999.tb00721.x","article-title":"Sudden cardiac death in familial hypertrophic cardiomyopathy: an Australian experience","volume":"29","author":"Semsarian","year":"1999","journal-title":"Aust N Z J Med"},{"issue":"1","key":"10.1016\/j.hfc.2010.05.004_bib57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/bjsm.30.1.5","article-title":"The athlete's heart: is big beautiful?","volume":"30","author":"Shephard","year":"1996","journal-title":"Br J Sports Med"},{"issue":"15","key":"10.1016\/j.hfc.2010.05.004_bib58","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/0002-9149(94)90290-9","article-title":"Surviving competitive athletics with hypertrophic cardiomyopathy","volume":"73","author":"Maron","year":"1994","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2010.05.004_bib59","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0002-9149(90)90585-O","article-title":"Sudden cardiac death associated with exercise: the risk- benefit issue","volume":"66","author":"Friedewald","year":"1990","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2010.05.004_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.epirev.a036091","article-title":"Physical activity, physical fitness, and sudden cardiac death","volume":"14","author":"Kohl","year":"1992","journal-title":"Epidemiol Rev"},{"issue":"11","key":"10.1016\/j.hfc.2010.05.004_bib61","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1249\/01.MSS.0000145443.02568.7A","article-title":"Physical activity and mortality across cardiovascular disease risk groups","volume":"36","author":"Richardson","year":"2004","journal-title":"Med Sci Sports Exerc"},{"issue":"11","key":"10.1016\/j.hfc.2010.05.004_bib62","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1249\/01.MSS.0000145536.87255.3A","article-title":"Adolescent correlates of adult physical activity: a 26-year follow-up","volume":"36","author":"Beunen","year":"2004","journal-title":"Med Sci Sports Exerc"},{"issue":"14","key":"10.1016\/j.hfc.2010.05.004_bib63","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jacc.2008.05.058","article-title":"A\u00a0critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death","volume":"52","author":"Tung","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2010.05.004_bib64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-9149(91)90440-V","article-title":"Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy","volume":"67","author":"Fananapazir","year":"1991","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2010.05.004_bib65","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/hrt.2006.099416","article-title":"Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy","volume":"93","author":"Melacini","year":"2007","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.hfc.2010.05.004_bib66","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","volume":"42","author":"Maron","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.hfc.2010.05.004_bib67","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/hrt.2008.154385","article-title":"Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice","volume":"94","author":"Elliott","year":"2008","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib68","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jacc.2009.03.051","article-title":"Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children","volume":"54","author":"Decker","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2010.05.004_bib69","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1017\/S1047951105001824","article-title":"Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly","volume":"15","author":"Ostman-Smith","year":"2005","journal-title":"Cardiol Young"},{"issue":"5","key":"10.1016\/j.hfc.2010.05.004_bib70","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients","volume":"42","author":"Monserrat","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2010.05.004_bib71","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/hrt.79.4.331","article-title":"Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population","volume":"79","author":"Cecchi","year":"1998","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.hfc.2010.05.004_bib72","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0735-1097(02)03004-8","article-title":"Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration","volume":"41","author":"Kofflard","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2010.05.004_bib73","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0735-1097(88)90181-7","article-title":"Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy","volume":"11","author":"McKenna","year":"1988","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.hfc.2010.05.004_bib74","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0735-1097(90)92820-R","article-title":"Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy","volume":"15","author":"Spirito","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.hfc.2010.05.004_bib75","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.hfc.2010.05.004_bib76","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0735-1097(95)00353-3","article-title":"Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population","volume":"26","author":"Cecchi","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2010.05.004_bib77","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.CIR.102.8.858","article-title":"Epidemiology of hypertrophic cardiomyopathy-related death \u2013 revisited in a large non-referral-based patient population","volume":"102","author":"Maron","year":"2000","journal-title":"Circulation"},{"issue":"9254","key":"10.1016\/j.hfc.2010.05.004_bib78","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(00)04005-8","article-title":"Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy","volume":"357","author":"Elliott","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.hfc.2010.05.004_bib79","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.echo.2006.01.005","article-title":"Use of echocardiography in patients with hypertrophic cardiomyopathy: clinical implications of massive hypertrophy","volume":"19","author":"Sorajja","year":"2006","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"5","key":"10.1016\/j.hfc.2010.05.004_bib80","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.amjcard.2009.04.039","article-title":"Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy","volume":"104","author":"Efthimiadis","year":"2009","journal-title":"Am J Cardiol"},{"issue":"21","key":"10.1016\/j.hfc.2010.05.004_bib81","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/eurheartj\/ehm117","article-title":"Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy","volume":"28","author":"McLeod","year":"2007","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib82","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000147887","article-title":"Myocardial bridging as a factor in heart disorders: critical review and hypothesis","volume":"157","author":"Yamaguchi","year":"1996","journal-title":"Acta Anat (Basel)"},{"issue":"17","key":"10.1016\/j.hfc.2010.05.004_bib83","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM199810223391704","article-title":"Myocardial bridging in children with hypertrophic cardiomyopathy \u2013 a risk factor for sudden death","volume":"339","author":"Yetman","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.hfc.2010.05.004_bib84","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/eurheartj\/ehp121","article-title":"Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death","volume":"30","author":"Basso","year":"2009","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hfc.2010.05.004_bib85","first-page":"1134","article-title":"Functional assessment of coronary stenoses","volume":"32","author":"Miller","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2010.05.004_bib86","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0003-4975(99)00482-8","article-title":"Supraarterial decompression myotomy for myocardial bridging in a child","volume":"68","author":"Hillman","year":"1999","journal-title":"Ann Thorac Surg"},{"issue":"13","key":"10.1016\/j.hfc.2010.05.004_bib87","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.108.798314","article-title":"Syncope and risk of sudden death in hypertrophic cardiomyopathy","volume":"119","author":"Spirito","year":"2009","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.hfc.2010.05.004_bib88","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.jacc.2004.03.035","article-title":"The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"43","author":"Moon","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2010.05.004_bib89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10554-007-9209-9","article-title":"Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia","volume":"24","author":"Dimitrow","year":"2008","journal-title":"Int J Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.hfc.2010.05.004_bib90","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jacc.2009.04.026","article-title":"Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia","volume":"54","author":"Kwon","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.hfc.2010.05.004_bib91","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2008.01.010","article-title":"Cardiovascular magnetic resonance for risk stratification of arrhythmia in hypertrophic cardiomyopathy","volume":"51","author":"Nazarian","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2010.05.004_bib92","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"J\u00a0Am Med Assoc"},{"issue":"1","key":"10.1016\/j.hfc.2010.05.004_bib93","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1540-8167.2004.03388.x","article-title":"Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics","volume":"15","author":"Alexander","year":"2004","journal-title":"J\u00a0Cardiovasc Electrophysiol"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713610000668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713610000668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T22:39:42Z","timestamp":1559687982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713610000668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1551713610000668"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2010.05.004","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}